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Abstract
It has been hypothesized that the ratio of heart rate variability in the low- (LF) and high- (HF) frequency bands may
capture variation in cardiac sympathetic control. Here we tested the temporal stability of the LF/HF ratio in 24-h
ambulatory recordings and compared this ratio to the preejection period (PEP), an established measure of cardiac
sympathetic control. Good temporal stability was found across a period of 3.3 years (.46oro.78), but the LF/HF
ratio did not show the expected negative correlation to PEP, either between or within subjects. We conclude that the
evidence to support the LF/HF ratio as a potential marker of cardiac sympathetic control in epidemiology-scaled
research is currently insufﬁcient.
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Because activity of the sympathetic nervous system (SNS) may
be paramount to the detrimental effects of stress on cardiovas-
cular health (Kamarck & Lovallo, 2003; Palatini & Jullius, 2004)
cardiovascular psychophysiologists need reliable and valid meth-
ods to measure SNS activity in humans. Ideally, such measures
should be noninvasive, unobtrusive, and cheap to allow ambu-
latory assessment in epidemiology-scaled samples. In response to
this need, Pagani and coworkers have suggested that spectral
power of the heart period time series in the lower frequencies
centered around 0.1 Hz (LF) divided by the power in the higher
frequencies centered around the respiratory frequency (HF) may
reliably capture changes in the ratio of sympathetic to vagus
nerve trafﬁc to the heart (Malliani, Pagani, Lombardi, & Cerutti,
1991; Pagani et al., 1986, 1991, 1997). Because recording of the
heart period time series requires nothing more complicated than
a three-lead ECG recording, spectral-power-derived LF/HF
ratios can be obtained in ambulatory paradigms in huge numbers
of subjects at very modest costs.
Although its use has become widespread, the LF/HF ratio is
not without controversy (Eckberg, 1997). The strongest concern
about the validity of the LF/HF ratio comes from studies that
directly compare it against invasive measures of sympathetic
activity, like direct recording of action potentials from superﬁcial
sympathetic nerves or assessment of cardiac norepinephrine
spillover by radioactive tracers.Most of these studies did not ﬁnd
a correlation between the LF/HF ratio and these sympathetic
measures across a range of clinical contexts, as reviewed by
Grassi and Esler (1999).
In defence of the LF/HF power it must be noted that these
studies were often performed in nonecological physiological
contexts; for example, within-subject variance in sympathetic
activity was usually induced by infusion of nitroprusside or
phenylephrine (Pagani et al., 1997; Saul, Rea, Eckberg, Berger,
& Cohen, 1990). Secondly, they were mostly performed on small
sample sizes that required the correlations to be in the .60–.80
range to be considered ‘‘signiﬁcant.’’ It is unlikely, however, that
LF/HF reﬂects cardiac sympathetic control that closely.
Whereas HF power relatively purely reﬂects cardiac vagal
control over the heart (Task Force of the European Society of
Cardiology and the North American Society of Pacing, 1996),
it is fully acknowledged that LF power is inﬂuenced by both
sympathetic and vagal activity. Hence, the LF/HF ratio will not
yield a perfect indicator of cardiac sympathetic control. Even so,
it may still retain sufﬁcient explanatory and predictive power to
be useful in epidemiology-scaled research.
In this study, we recorded ambulatory LF and HF power in
64 subjects and reassessed these powers after an average of 3.3
years to establish temporal stability of the ambulatory LF/HF
ratio. We next compared the LF/HF ratio, both within and
between subjects, to an alternative measure of cardiac sympa-
thetic control, the preejection period (PEP), which can be
obtained by ambulatory recording of the thoracic impedance
cardiogram (Kupper, Willemsen, Boomsma, & de Geus,
2006; Riese et al., 2003). Changes in PEP reﬂect changes in
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b-adrenergic inotropic drive to the left ventricle, provided
subjects are compared in the same posture (Houtveen, Groot,
& de Geus, 2005; Sherwood et al., 1990). If the LF/HF ratio is
a valid measure of cardiac sympathetic control, it should show
a negative correlation to the PEP, such that longer PEPs are
associated with lower LF/HF ratios.
Methods
Participants
Participants were all registered with the Netherlands Twin
Register (NTR). They came from families that participated in
a genetic linkage study searching for genes inﬂuencing person-
ality and cardiovascular disease risk, which is described elsewhere
(Boomsma et al., 2000). Out of the 1,332 twins and siblings
who participated in the linkage study, 816 were also willing to
participate in cardiovascular ambulatory monitoring (Kupper
et al., 2006). To establish temporal stability, 65 volunteers
(20 male, 45 female) were re-recruited for a second ambulatory
recording day after an average of 3 years 4 months (minimum of
2 years 1 month and maximum of 4 years 8 months). These 65
subjects with two repeated test days form the basis of the current
study. At the ﬁrst test day their ages ranged from 18 to 62 years
(mean5 30.7, SD5 9.7).
Procedure
A detailed description of the ambulatory monitoring procedure
has been provided elsewhere (Goedhart, Kupper, Willemsen,
Boomsma, & deGeus, 2006; Goedhart, van der Sluis, Houtveen,
Willemsen, & de Geus, 2007; Kupper et al., 2006). Brieﬂy,
subjects were ﬁtted with the Vrije Universiteit Ambulatory
Monitoring System that recorded the electrocardiogram (ECG)
and the impedance cardiogram (ICG) continuously during a
24-h period (daytime and sleep) through six disposable, pregelled
Ag/AgCl electrodes. During the daytime and evening, partici-
pants were regularly prompted to give a chronological account
of posture, physical activity, physical load, location, and social
situation during the last 30-min period. Using the activity diary
entries in combination with a visual display of an in-built vertical
accelerometer signal, the entire 24-h recording was divided into
ﬁxed periods coded for posture (e.g., lying, sitting, standing),
ongoing activity (e.g., desk work, eating/drinking, meetings,
watching TV), physical activity (no, light, medium, and heavy),
location (e.g., work, home, outside), and social situation (e.g.,
alone, with colleagues, with friends). An average of 27 coded
periods was created per subject with a mean duration of 30 min
(minimum 5 min, maximum 60 min).
PEP and LF/HF Registration
Large-scale ensemble averaging of the ICG signals was per-
formed to obtain the mean PEP per coded period as outlined in
detail by Riese et al. (2003) and Kupper et al. (2006). From the
ECG and the dZ, we obtained the heart period time series and
respiration signal (Goedhart et al., 2007; Houtveen et al., 2005).
In keeping with PEP scoring, mean LF and HF powers were
computed across the entire coded period. We used a Wavelet
approach, which has some advantages over the more com-
mon Fourier approach as discussed elsewhere (Houtveen &
Molenaar, 2001). The LF power was computed as the variance
in the 0.0625–0.125-Hz window and HF power as the variance
in the 0.125–0.5-Hz window. From these, the LF/HF ratio was
computed as well as the LF power in normalized units (LFnu),
which is the LF power divided by the sum of the LF and HF
powers. Although it has been suggested that LFnu and LF/HF
ratio can be considered equivalent carriers of information (Burr,
2007), we present full data on absolute LF, LFnu, and LF/HF
ratio for completeness.
Results
Table 1 presents the untransformed means and standard devia-
tions for PEP and the heart rate variability measures separately
during sleep, awake sitting, and mild physical activity. Because
the LF/HF ratio and the LF, HF, and LFnu power distributions
were skewed, their natural logarithms were used in all further
analyses.
Table 1 also reports the temporal stability that was assessed by
intraclass correlation, computed separately for nighttime sleep,
sitting during the day, and mild physical activity (standing/
walking). Good temporal stability for LF,HF, andLFnu powers
and the LF/HF ratio was found over an average period of 3 years
4 months during sitting and sleep. Correcting HF power for
changes in respiration rate (residualized HF powerHFres) did
not further improve stability. Physical activity, which is inher-
ently less comparable across repeated test days, produced lower
estimates.
Table 2 show the within-subject correlations of PEP and the
heart rate variability measures during sitting activities across the
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Table 1. Means (SD) of PEP and Heart Rate Variability Measures and Temporal Stability across the Two Test Days (N5 64)
Condition PEP (ms) LF (ms2) HF (ms2) LF/HF LFnu
Sleep
Test day 1 105.39 (11.62) 1023.75 (804.09) 1080.64 (1039.62) 1.26 (.66) 51.41 (11.61)
Test day 2 107.53 (13.18) 975.72 (1025.26) 901.74 (1093.50) 1.43 (.79) 54.30 (11.52)
Temporal stability .71 .80 .79 .64 .72
Sitting
Test day 1 97.43 (12.42) 829.59 (556.60) 666.57 (723.62) 1.74 (.82) 59.39 (8.92)
Test day 2 97.11 (13.18) 764.68 (580.30) 592.72 (658.77) 1.76 (.75) 59.81 (8.69)
Temporal stability .80 .82 .79 .70 .70
Mild physical activity
Test day 1 98.58 (11.94) 689.29 (400.47) 578.83 (553.61) 1.69 (.78) 58.47 (10.41)
Test day 2 96.33 (13.36) 666.96 (412.77) 444.36 (346.64) 1.93 (.79) 61.58 (8.14)
Temporal stability .76 .62 .57 .53 .53
Note: Correlations signiﬁcant at po.05 are in bold.
two 24-h measurements. The median within-subject correlation
between PEP and the LF/HF ratio was exactly zero. Only 3 out
of 64 subjects showed a signiﬁcant correlation in the expected
(negative) direction. For absolute LF power, not a single subject
showed the expected signiﬁcant negative correlation. Inspection
of each test day separately also failed to reveal signiﬁcant LF/HF
to PEP correlations.
Median within-subject correlations between LF and HF
power were unanimously high (LF and HF, r5 .72). Correction
for within-subject changes in respiration barely inﬂuenced this
correlation (LF and HFres, r5 .71).
Table 3 shows the between-subject correlations separately
within each of the threemain ambulatory conditions for both test
days. Partial correlations were computed controlling for the
effect of sex and age. During sleep, none of the correlations be-
tween PEP and the heart rate variability measures were signiﬁ-
cant. During sitting and physical activity on Day 2 a signiﬁcant
correlation between PEP and the LF power was found, but the
direction was opposite to the expectation.
Between-subject correlation for LF andHF all exceed .79 in all
three conditions on both test days, indicating high overlap between
the two measures of heart rate variability. Again, partialling out
respiration rate barely affected the LF–HF correlation.
Discussion
The notion has been advanced that a single ratio, spectral power
of the heart period time series in the lower frequencies centered
around 0.1 Hz (LF) divided by the power in the higher frequen-
cies centred around the respiratory frequency (HF), may capture
differences in cardiac sympathetic control, even if imperfectly
(Malliani et al., 1991; Pagani et al., 1986, 1991, 1997). Here
we used prolonged ambulatory recordings on two test days to
establish temporal stability of the LF/HF ratio and to test
whether it was correlated within and between subjects with the
PEP, an established measure of cardiac sympathetic control.
Although good temporal stability was found across a period
of 3.3 years, the LF/HF ratio did not show the expected negative
correlation to PEP, either between or within subjects. The
most parsimonious conclusion from these results is that PEP and
LF/HF do not measure the same physiological phenomenon;
they appear to be ‘‘two sides of a different coin.’’ The important
question then becomes which of the twomeasures reﬂects cardiac
sympathetic control best. Studies using manipulations known to
increase cardiac sympathetic activity like mental stress and
exercise currently suggest that the PEP outperforms the LF/HF
ratio as an index of sympathetic control. Mental or emotional
stress increases the LF power in some studies (Langewitz &
Ruddel, 1989) but not in all (Hoshikawa & Yamamoto, 1997;
Tulen, Boomsma, & Veld, 1999), whereas these stressors system-
atically shorten the PEP (Berntson et al., 1994; deGeus, Kupper,
Boomsma, & Snieder, 2007; Houtveen et al., 2005; Sherwood
et al., 1990). Furthermore, cardiac sympathetic activation
induced by exercise sometimes evokes a decrease in LFnu power
rather than the expected increase (Ahmed, Kadish, Parker, &
Goldberger, 1994), whereas systematic and dose-dependent
shortening of the PEP is seen during exercise (Houtveen,
Rietveld, & de Geus, 2002; Smith et al., 1989). Finally, PEP
shows more speciﬁcity in response to autonomic blockade than
the LF/HF ratio. Acute b-adrenergic blockade does not give rise
to the expected reduction in LF power (Pagani et al., 1986) and
may even cause an increase in LF power (Jokkel, Bonyhay, &
Kollai, 1995) whereas cholinergic blockade by atropine causes a
substantial reduction or even elimination of LF ﬂuctuations
(Akselrod et al., 1981; Jokkel et al., 1995). In contrast, acute
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Table 2. Within-Subject Correlations between PEP and HRV
Measures during the Posture Sitting
Parti-
cipant no. Age N
PEP-
LF
PEP-
HF
PEP-
HFres
PEP-
LF/HF
PEP-
LFnu
LF-
HF
LF-
HFres
1 18.0 26 .04 .03 .06  .01 .00 .82 .80
2 18.9 40  .07  .51  .53 .56 .52 .67 .60
3 18.9 26  .20 .08 .03  .15  .24 .68 .68
4 20.2 23 .13  .03  .03 .14 .11 .42 .40
5 21.9 31 .36 .28 .25 .08 .07 .64 .60
6 23.0 30 .01  .03  .07 .05 .06 .09 .10
7 23.0 14  .04  .30  .30 .36 .34 .66 .59
8 23.1 16  .01 .41 .39  .34  .32 .57 .52
9 23.5 33  .10  .01  .07  .08  .07 .37 .36
10 23.9 23 .61 .80 .80  .78  .77 .87 .87
11 24.0 27 .18 .04  .05 .24 .26 .84 .80
12 24.6 32 .31 .30 .18 .07 .10 .63 .62
13 24.7 32  .34  .38  .31 .09 .06 .83 .77
14 24.9 43 .26 .17 .30 .19 .19 .70 .59
15 25.2 17 .30 .32 .22  .09  .05 .83 .79
16 25.6 28 .13 .28 .32  .33  .33 .86 .85
17 26.6 21 .27 .10 .09 .25 .19 .87 .84
18 26.8 23 .17  .01 .05 .30 .30 .81 .81
19 27.1 40 .06  .30  .43 .37 .36 .46 .43
20 27.5 36 .33 .12 .10 .22 .25 .62 .61
21 28.0 40 .29 .30 .27 .04 .08 .86 .85
22 28.5 27 .58 .47 .50 .06 .06 .55 .52
23 28.5 16 .31 .29 .25  .08  .04 .71 .72
24 28.6 29 .10 .18 .16  .14  .14 .51 .51
25 29.5 23 .61 .26 .28 .52 .67 .85 .86
26 30.0 29  .13 .25 .27  .39  .39 .55 .51
27 30.7 23 .04 .52 .53  .61  .66 .67 .65
28 31.2 23 .11 .47 .52  .51  .46 .58 .55
29 32.7 25  .12 .23 .26  .47  .49 .73 .74
30 32.9 25 .62 .55 .53  .33  .29 .92 .90
31 32.9 20 .27 .20 .22 .10 .08 .95 .94
32 35.3 21 .16  .11  .14 .33 .34 .73 .71
33 36.6 29 .14 .12 .12 .09 .08 .89 .87
34 40.3 21 .53 .24 .18 .23 .33 .76 .71
35 42.1 32 .08 .02  .05 .06 .07 .70 .65
36 42.1 36 .44 .28 .27  .02 .07 .70 .67
37 42.7 30 .17 .27 .27  .28  .26 .76 .73
38 44.0 26 .09 .20 .17  .09  .08 .31 .35
39 44.1 22 .02  .26  .14 .30 .28 .42 .40
40 47.3 28 .15  .07  .13 .29 .30 .71 .39
41 47.5 37 .44 .38 .40  .18  .22 .95 .94
42 48.3 26  .06 .11 .16  .23  .27 .83 .82
43 48.4 23 .59 .72 .72  .30  .31 .95 .94
44 62.3 32 .05 .42 .37  .44  .45 .70 .69
45 19.5 30 .42 .43 .46  .08  .01 .49 .47
46 19.7 22 .15 .24 .23  .19  .13 .74 .73
47 20.5 30 .37 .36 .34  .21  .04 .34 .33
48 22.5 24 .38 .44 .44  .18  .19 .96 .96
49 24.7 33 .41 .45 .52  .07  .05 .61 .58
50 25.0 25 .08 .02 .04 .04 .10 .79 .78
51 25.1 46 .12  .27  .26 .46 .49 .69 .68
52 25.3 21 .62 .54 .51  .22  .16 .91 .89
53 25.4 30 .19 .16 .19 .09 .08 .89 .86
54 25.8 24 .01  .06 .03 .08 .11 .87 .86
55 27.0 15 .05  .07  .08 .28 .32 .94 .94
56 27.8 37 .22 .05 .03 .16 .14 .43 .38
57 28.0 23 .37 .11 .13 .39 .41 .78 .77
58 28.5 19 .05 .38 .33  .31  .29 .35 .31
59 31.4 28 .07 .25 .20  .32  .24 .68 .61
60 33.0 27 .14 .41 .45  .55  .52 .84 .82
61 38.6 32 .02 .06 .01  .06  .05 .80 .78
62 45.6 28  .03 .13 .21  .26  .22 .74 .73
63 47.1 25 .31 .35 .27 .06 .06 .74 .74
64 50.8 30  .01  .03 .09 .01 .03 .68 .65
Median 30.9 27 .15 .20 .19 .00 .05 .72 .71
Note: Bold signiﬁes that the correlation is signiﬁcant at the .01 level.
b-receptor blockade always prolongs PEP (Cacioppo et al., 1994;
Sherwood et al., 1990; Winzer et al., 1999) whereas atropine
leaves it unchanged (Cacioppo et al., 1994).
In conclusion, we ﬁnd that in ambulatory data the PEP
and the LF/HF ratio are uncorrelated, either within or be-
tween subjects. The predictive power of both LF and HF power
for cardiovascular disease is beyond question (Dekker et al.,
2000; Tsuji et al., 1996), as is the usefulness of ambulatory
recording of these two aspects of heart rate variability. How-
ever, the evidence to support ambulatory LF/HF ratio as
a potential marker of cardiac sympathetic nerve control may be
insufﬁcient.
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